Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Touyun Tech Group ( (HK:1332) ) has provided an announcement.
Touyun Biotech Group Limited announced an unusual increase in its share price and trading volume, with no known reasons for these movements. The company confirmed that its operations remain normal and disclosed a strategic cooperation agreement with a sales consortium to purchase Chlamydomonas reinhardtii products worth at least RMB1 billion from 2026 to 2028, indicating potential growth opportunities.
The most recent analyst rating on (HK:1332) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Touyun Tech Group stock, see the HK:1332 Stock Forecast page.
More about China Touyun Tech Group
Touyun Biotech Group Limited, incorporated in Bermuda, operates in the biotechnology industry. The company, along with its subsidiaries, focuses on producing and marketing Chlamydomonas reinhardtii and related products, with a strategic market focus on expanding its reach through collaborations.
Average Trading Volume: 1,589,265
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.08B
See more data about 1332 stock on TipRanks’ Stock Analysis page.